Your browser doesn't support javascript.
loading
Thyroid hormone resistance in two patients with papillary thyroid microcarcinoma and their BRAFV600E mutation status
Karakose, Melia; Caliskan, Mustafa; Arslan, Muyesser Sayki; Cakal, Erman; Yesilyurt, Ahmet; Delibasi, Tuncay.
  • Karakose, Melia; Diskapi Yildirim Beyazit Training and Research Hospital. Department of Endocrinology and Metabolism. Ankara. TR
  • Caliskan, Mustafa; Diskapi Yildirim Beyazit Training and Research Hospital. Department of Endocrinology and Metabolism. Ankara. TR
  • Arslan, Muyesser Sayki; Diskapi Yildirim Beyazit Training and Research Hospital. Department of Endocrinology and Metabolism. Ankara. TR
  • Cakal, Erman; Diskapi Yildirim Beyazit Training and Research Hospital. Department of Endocrinology and Metabolism. Ankara. TR
  • Yesilyurt, Ahmet; Diskapi Yildirim Beyazit Training and Research Hospital. Department of Endocrinology and Metabolism. Ankara. TR
  • Delibasi, Tuncay; Diskapi Yildirim Beyazit Training and Research Hospital. Department of Endocrinology and Metabolism. Ankara. TR
Arch. endocrinol. metab. (Online) ; 59(4): 364-366, Aug. 2015.
Article Dans Anglais | LILACS | ID: lil-757371
ABSTRACT
Resistance to thyroid hormone (RTH) is a rare autosomal dominant hereditary disorder. Here in, we report two patients with RTH in whom differentiated thyroid cancer was diagnosed. Two patients were admitted to our clinic and their laboratory results were elevated thyroid hormone levels with unsuppressed TSH. We considered this situation thyroid hormone resistance in the light of laboratory and clinical datas. Thyroid nodule was palpated on physical examination. Thyroid ultrasonography showed multiple nodules in both lobes. Total thyroidectomy was performed. The pathological findings were consistent with papillary thyroid microcarcinoma. BRAFV600E mutation analysis results were negative. RTH is very rare and might be overlooked. There is no consensus on how to overcome the persistently high TSH in patients with RTH and differentiated thyroid cancer (DTC). Further studies are needed to explain the relationship between RTH and DTC which might be helpful for the treatment of these patients.
Sujets)

Texte intégral: Disponible Indice: LILAS (Amériques) Sujet Principal: Carcinome papillaire / Syndrome de résistance aux hormones thyroïdiennes / Mutation Limites du sujet: Adulte / Femelle / Humains / Mâle langue: Anglais Texte intégral: Arch. endocrinol. metab. (Online) Thème du journal: Endocrinologie / Métabolisme Année: 2015 Type: Article Pays d'affiliation: Turquie Institution/Pays d'affiliation: Diskapi Yildirim Beyazit Training and Research Hospital/TR

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS


Texte intégral: Disponible Indice: LILAS (Amériques) Sujet Principal: Carcinome papillaire / Syndrome de résistance aux hormones thyroïdiennes / Mutation Limites du sujet: Adulte / Femelle / Humains / Mâle langue: Anglais Texte intégral: Arch. endocrinol. metab. (Online) Thème du journal: Endocrinologie / Métabolisme Année: 2015 Type: Article Pays d'affiliation: Turquie Institution/Pays d'affiliation: Diskapi Yildirim Beyazit Training and Research Hospital/TR